EUROAPI news, videos and press releases
For more news please use our advanced search feature.
EUROAPI - More news...
EUROAPI - More news...
- Olivier Falut appointed EUROAPI’s Chief Financial Officer
- EUROAPI closes the financing of its FOCUS-27 plan
- H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap
- EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
- Availability of the 2023 Universal Registration Document, including the Annual Financial Report
- EUROAPI: Availability of 2023 Half-Year Financial Report
- EUROAPI: H1 2023 RESULTS
- Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe
- EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins
- EUROAPI: Combined General Meeting of May 11, 2023
- EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director
- EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects
- EUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document
- EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report
- EUROAPI: Full-Year 2022 Results
- EUROAPI: Progressive restart of prostaglandin production at Budapest site
- EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director
- Vitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France
- EUROAPI Updates Its 2022 Financial Guidance
- EUROAPI to Reach 500 kg Peptide and Oligonucleotide Capacity Per Year in Frankfurt by 2025
- EUROAPI: Availability of 2022 Half-Year Financial Report
- EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed
- EUROAPI Announces the Success of Its First Global Employee Share Plan “EUROAPI Action 2022”
- ESG: EUROAPI Moves Forward With Its Carbon Reduction Ambition and Invests to Build a State-of-the-Art Biomass Boiler in France
- Availability of EUROAPI’s 2021 Half-Year Results
- EUROAPI joins the SBF 120 and CAC Mid 60 indices
- EUROAPI launches its first global employee share plan “EUROAPI Action 2022”
- EUROAPI Implements a Liquidity Contract With Kepler Cheuvreux
- CDMO: EUROAPI Supports Sanofi’s mRNA Vaccine Platform with the Development of Lipid Nanoparticles
- EUROAPI Announces Its Successful Listing on Euronext Paris
